Biomedical, Clinical & Life Sciences

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Limiting Language
The University of Arizona Cancer Center (UACC) can nominate one proposal for the Breast Cancer Alliance Research Awards - either for the Young Investigator Grant (YIG) OR Exceptional Project Grant (XP) 2026.

Purpose of Award:

Breast Cancer Alliance provides seed money – scientific venture capital – to fund innovative breast cancer research with emphases on programs that have not yet qualified for federal grants. To secure federal funding, a researcher must prove a theory works. Breast Cancer Alliance creates the critical bridge between novel research and the opportunity to generate preliminary results with grants like our Exceptional Projects.

BCA encourages careers in breast cancer research and in clinical medicine. We award two year Young Investigator Grants to doctors and scientists in the early stages of their careers, often overlooked by the funding world until they have longer tenure. 

• YIG:
  • Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for a Young Investigator Grant. 
  • This award helps advance the careers of young researchers who do not yet have their own major grant support, but who design and conduct their own independent research projects.
• XP:
  • Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant. 
  • This award recognizes creative, unique and innovative research related to breast cancer.

Apply to Internal Competition // Limit: 2* // Tickets Available: 2 

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Limiting Language
The University of Arizona Cancer Center (UACC) can nominate can nominate up to two proposals: one Translational OR V Scholar nominee and one All-Star nominee (if eligible) for the V Foundation Pediatric Cancer Research Grant 2026.

Purpose of Award
The UACC is seeking nominations for the Pediatric Cancer Research Grant which is restricted to pediatric cancer research. Research on ANY pediatric cancer type can be funded. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Applicant Eligibility
Nominee must meet all of the following criteria by the nomination due date:

• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or a permanent legal resident in the US
• See additional criteria for each mechanism listed in corresponding RFA within the Supporting Documents section above.

Funding Information per mechanism

• V Scholar: A four-year grant totaling $800,000 (paid in annual installments of $200,000). No indirect costs allowed.
• Translational: A four-year grant totaling $800,000 (paid in annual installments of $200,000). This amount includes both direct and indirect costs. Indirect costs are allowed up to 10% of total grant amount.
• All Star: A five-year grant totaling, $1,000,000 (paid in annual installments of $200,000). This amount includes both direct and indirect costs. Indirect costs are allowed up to 10% of total grant amount.

The V Foundation follows NIH salary cap guidelines. Institutions may supplement a grant recipient’s salary with institutional funds, if desired.

Apply to Internal Competition // Limit: One LOI per College

Limiting Language
Organizations may submit only one Letter of Inquiry per deadline. Common exceptions include LOIs submitted by separate departments of large universities. Per clarification with RRF, the University of Arizona may submit one LOI per college per deadline. 

Program Description

Full sponsor guidelines are linked here. 

RRF Foundation for Aging focuses on improving the quality of life for older people. In an effort to strengthen the Foundation’s impact, RRF has established Priority Areas. These Priority Areas are specific topics in aging that will be given higher priority within the Foundation’s grantmaking program.

Types of Grants

1. Advocacy: Achieve enduring social change around issues that affect older Americans
2. (Ineligible - for applicants in Illinois only) Direct Service: Improve availability and quality of community-based services and supports in seven states
3. Research: Seek causes and solutions to significant problems for older persons
4. Knowledge Sharing and Awareness Raising: Knowledge sharing and awareness-raising projects that convey meaningful information, shape narratives, and drive positive change.
5. (Ineligible - for applicants in Illinois only) Organizational Capacity Building: Improve management and governance of non-profit organizations

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
You may only submit one application under this NOFO.

Purpose
CMS, through its Center for Clinical Standards and Quality (CCSQ), is accepting applications for cooperative agreements to entities to administer financial incentives, such as loan repayment and stipends, to RNs and LPNs to work in a qualifying nursing home or in an oversight role with a state agency for three years.

CMS will enter into cooperative agreements with organizations, which will become Financial Incentive Administrators (FIAs). These FIAs will identify and accept applications from individuals, who would then receive funds contingent on their working in a qualifying nursing home or state survey agency for three years (with an average of 30 or more hours per week).

In addition, FIAs will coordinate closely with individual states, which will provide additional funding directly to the FIA to increase the number of financial incentives available to recruit nurses in their state, and to gain a deeper understanding of each state’s specific staffing needs. FIAs will also work with other stakeholders, such as nursing homes, associations, or private organizations, which may contribute additional funds to the campaign or identify other ways to enhance the program.

The number of allowed institutional submissions is no longer limited by the Beckman Foundation. Per the funding opportunity webpage: Institutions are not limited in the number of applicants who apply at the Letter of Intent stage.

If you are interest in applying, please contact Marie Teemant at marieteemant@arizona.edu 
 

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
An institution may only submit one LOI per award type. 

Program Overview
Emerging Investigator Fellowship Grants (up to $75,000 for one year) These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. Applicants must have completed two years of their fellowship or not more than two years as a junior faculty instructor or assistant professor at the start of the award period. These grants encourage and cultivate the best and brightest researchers of the future. 

Internal Competition Undergoing Peer Review for Basic through Preclinical Research // Request Ticket for Clinical through Public Health Research Nomination // Limit: 2 (one in basic science/preclinical research and in clinical through public health research) // Tickets Available: 1

Basic through Preclinical Research // Limit: 1 // Tickets Available: 0

Clinical through Public Health Research // Limit: 1 // Tickets Available: 1

Limiting Langauge
Each institution is allowed a maximum of two (2) nominations per grant cycle: one (1) applicant must be focused on basic science/preclinical research and one (1) applicant must be focused on translational science. Each nomination can be for either of the Pathway Program Award types: Initiator or Accelerator. Please be aware that if an institution nominates two (2) applicants with proposed projects covering the same phase of research (i.e. basic through preclinical research studies), one of the submitted applications will be administratively disqualified from consideration for funding. 

Program Summary
The Pathway to Stop Diabetes® program intends to attract brilliant scientists approaching the peak of their careers in diabetes research, and to accelerate their research progress by providing the necessary resources and support for conducting transformative science. 

This call for nominations will prioritize exceptional investigators across the spectrum of diabetes research, spanning basic science through public health research and implementation science. The ideal applicant will propose innovative research with the ultimate goal of improving the lives of people at risk of diabetes or living with the disease - and the pathway to this impact is clear. 

Starting in 2024, ADA will accept up to two (2) nominations per institution with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research. 

Examples of basic through preclinical research studies (for nomination #1) include: 

• Innovative mechanistic studies on fundamental or new aspects of biology
• Novel insights derived from data science using AI/Machine Learning
• Development of new technologies, devices, and/or experimental approaches 

Identification and validation of novel and unique therapeutic targets 

Examples of clinical through public health research (for nomination #2) include: 

• Clinical experimental medicine studies
• Identification and validation of novel biomarkers
• Health services research
• Behavioral research
• Population epidemiology
• Health economics research
• Patient preference / Quality of Life
• Dissemination and implementation science
• Health Care system-based interventions 

Nominations are welcomed from all areas of diabetes and span prevention, management, and cure of all diabetes types (i.e. type 1, type 2 and gestational), diabetes-related disease states (obesity, prediabetes, and other insulin resistant states) and complications. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics, and physics. 

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language 
An organization can submit only one application as the Lead Organization. Eligible organizations are welcome to collaborate with nonprofit organizations, companies, foundations, schools, colleges and universities, government agencies, individuals, and other entities (either U.S.-based or non-U.S.-based) to develop the solution. An organization can also serve as a partner on a team for multiple applications provided that each application proposes a separate, distinct solution

About the Challenge 
Building on its long-standing commitment to improve lives and communities, the Elevance Health Foundation recently launched a new initiative: Community Action Leadership. This initiative brings together external thought leaders from across a range of disciplines. Through their collective expertise and resources, the Foundation is addressing large-scale community health needs and incentivizing action for change. The inaugural Community Action Leadership challenge focuses on patient safety.

The Patient Safety Prize invites pioneering solutions in three key areas:

• Empowering Health Literacy for Safer Patient Care
• Innovating to Eliminate Medication Errors
• Promoting Fall-Free Futures

Request Ticket // Limit: 2 // Tickets Available: 1

E. Yamoah (Translational Neuroscience, COM-P)

Limiting Language
Two applications per institution (with a Unique Entity Identifier ) and a unique NIH eRA Institutional Profile File (IPF) number) are allowed per review round. The same or a similar topic may be submitted for subsequent review rounds involving the same or a similar team, but must be presented as a New application, not a Resubmission.

Program Description 
This Funding Opportunity Announcement (FOA) is designed to support highly integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to address ambitious and challenging research questions that are within the mission of NIGMS. Project goals should not be achievable with a collection of individual efforts or projects. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields.

This FOA is not intended for applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development.

Request Ticket // Limit: 2 // Tickets Available: 1
 
K. Rodgers (Pharmacology) and C. Valencia (Family and Community Medicine) - Target Population: Junior and High School Teachers


Limiting Language
No more than two applications are allowed per institution. If two applications are submitted, then the two awards must be for different target groups.

Additional detail from the Program Officer: The two target populations are up the applicant institution. If two applications targeting undergraduates are submitted, it is incumbent on the applicant institution to directly address how the two programs are distinct.

Purpose